Skip to main content

Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)

Tipranks - Tipranks - Thu Feb 12, 8:50AM CST

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health today and set a price target of $100.00.

Valentine's Day Sale - 70% Off

Anderson CFA covers the Healthcare sector, focusing on stocks such as Align Tech, Henry Schein, and Doximity. According to TipRanks, Anderson CFA has an average return of -2.1% and a 48.60% success rate on recommended stocks.

In addition to Evercore ISI, CVS Health also received a Buy from Truist Financial’s David S Macdonald in a report issued today. However, on the same day, TipRanks – Anthropic reiterated a Hold rating on CVS Health (NYSE: CVS).

See the top stocks recommended by analysts >>

Based on CVS Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $105.69 billion and a net profit of $2.94 billion. In comparison, last year the company earned a revenue of $97.71 billion and had a net profit of $1.64 billion

Read More on CVS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).